$KIDS Cashflow Statement | Understand Stock

$KIDS

$23.82 -$0.20 (0.83%) Close

$KIDS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES
Net loss
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Loss on sale of discontinued operations
Impairment
ApiFix
Total impairment

Goodwill and other intangible asset impairments
Depreciation and amortization
Loss on early extinguishment of debt
Stock-based compensation
Fair value adjustment of contingent consideration
ApiFix
Total fair value adjustment of contingent consideration
Accretion of acquisition installment payable
Deferred income taxes
Non-cash other
Changes in certain operating assets and liabilities, net of acquisitions:
Accounts receivable - trade
Inventories
Prepaid expenses and other current assets
Accounts payable - trade
Accrued legal settlements
Accrued expenses and other liabilities
Other

Net cash used in operating activities - continuing operations
Net cash used by operating activities - discontinued operations
Net cash used in operating activities

INVESTING ACTIVITIES
Other acquisitions, including clinics, net of cash acquired
Acquisition of MedTech, net of cash acquired
Sale of short term investments
Purchase of short term investments
Acquisition of Rhino assets
Acquisition of MDO, net of cash acquired
Acquisition of Pega, net of cash acquired
Acquisition of Devise Ortho assets
Sale of short-term marketable securities
Purchase of short-term marketable securities
Investment in private companies and purchases of licenses
Band-Lok intangible assets
Licenses
Total investment in private companies and purchases of licenses

Purchases of property and equipment
Net cash (used in) provided by investing activities

FINANCING ACTIVITIES
Payments on debt with affiliate
Proceeds from issuance of debt with affiliate
Related Party
Nonrelated Party
Total proceeds from issuance of debt with affiliate

Proceeds from issuance of debt
Related Party
Nonrelated Party
Total proceeds from issuance of debt
Payment of debt issuance costs
Proceeds from issuance of common stock, net of issuance costs
Proceeds from exercise of stock options
Installment payments
ApiFix
Medtech
Clinic Acquisitions
Total installment payments
Payments on mortgage notes
Payment on debt
Related Party
Nonrelated Party
Total payment on debt
Net cash provided by financing activities
Effect of exchange rate changes on cash
NET (DECREASE) INCREASE IN CASH AND RESTRICTED CASH
Cash and restricted cash, beginning of period
Cash and restricted cash, end of period
SUPPLEMENTAL DISCLOSURES
Cash paid for interest
Transfer of instruments between property and equipment and inventory
Issuance of common shares in acquisition
Vilex and Orthex
Telos
ApiFix
ApiFix acquisition installment
Band-Lok
Medtech
Boston Brace International, Inc.
Rhino
MD Orthopaedics
Devise Ortho
Vendor
Distributor

Divestiture consideration allocated to assets held for sale (See Note 4)
Payment of Term Note B with revolving credit facility (See Note 9)
Right-of-use assets obtained in exchange for lease liabilities
Capital contribution associated with reclassification of liability to equity
Debt issuance costs not yet paid

Comments